Zeftera (previously Zevtera) (ceftobiprole)
- Region
- 🇪🇺 EU
- Active substance
- ceftobiprole
- Company
- Janssen-Cilag International NV
- Status
- Refused
- Therapeutic area
- Skin Diseases, Infectious; Soft Tissue Infections
- CHMP opinion
- Thu 24 Jun 2010
- Application
- EMEA/H/C/000883
- ATC
- J01DI01
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Follow Zeftera (previously Zevtera)
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.